Human Genome Sciences, GlaxoSmithKline sales and marketing update

In a presentation, Human Genome Sciences said it and partner GlaxoSmithKline launched Benlysta belimumab in the U.S. to treat patients with active, autoantibody-positive systemic lupus

Read the full 254 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE